Looking forward, Veeva is expected to see a deceleration in the rate of revenue growth in FY26, which could be due to tougher ...

The year 2025 is witnessing a significant expansion of the Medical Info Systems industry, fueled by new federal policies and strong regulatory support. A major catalyst is Donald Trump's $500 billion ...

Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial Veeva ...

Veeva Systems is overvalued, trading at frothy levels despite only ~10% growth, and facing a potential slowdown in 2025; I recommend a sell rating. The company excels in the life sciences vertical ...

Commercial services player EVERSANA has joined the growing number of companies partnering with Veeva Systems – a specialist in cloud software for the life sciences industry – on the ...

Yet, this upbeat vision is being undercut by another cornerstone of Trump's economic ... 3 Medical Info Systems Stocks to Bet On Veeva Systems offers cloud-based software applications and data ...

In the latest market close, Veeva Systems (VEEV) reached $232.07, with a -0.69% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.63% for the ...